Eris Lifesciences gets nod to hike foreign investors’ limit to 49%

23 Aug 2017 Evaluate

Eris Lifesciences has received an approval from Reserve Bank of India (RBI) to raise foreign investors’ stake in the company to 49%. RBI notified that Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) investment limit under Portfolio Investment Scheme (PIS) in the company has increased from 24% to 49% of its paid up capital. Also, the NRI investment limit under PIS in the company has increased from 10% to 24%.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.


Eris Lifesciences Share Price

892.50 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1535.15
Dr. Reddys Lab 5814.80
Cipla 1414.95
Zydus Lifesciences 1120.00
Lupin 1656.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.